ARTICLE | Company News
RXi Pharmaceuticals, TransDerm deal
April 19, 2010 7:00 AM UTC
The companies partnered to evaluate transdermal delivery of RXi's sd-rxRNA compounds using TransDerm's delivery technology to treat dermatological diseases, including pachyonychia congenita, a rare ge...